QA: Applied Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001697532_2023_Applied_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001697532, Applied Therapeutics Inc

  xvar xval
0 AssetsCurrent 37,308,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,055,000
4 LiabilitiesCurrent 33,424,000
5 LiabilitiesNoncurrent 878,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,792,552
9 ResearchAndDevelopmentExpense 48,744,453
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 148,853
13 remainder_ComprehensiveNetIncome 200,280
  yvar yval
0 Assets 38,363,000
1 Liabilities 34,302,000
2 Expenses 63,537,005
3 Revenues 0
4 StockholdersEquity 4,061,000
5 NetIncome -63,388,152
6 ComprehensiveNetIncome -63,288,012
7 BaseVar 68,275,569
8 EconomicCapitalRatiobeforeLimitedLiability -1.50
9 EconomicCapitalRatio 1.18

Edgar->Model Mapping

Feature Distribution

Change over Time